By Amy Carl
Michigan State University just broke ground on a cutting-edge medical research center. Set to open in 2017, the center’s 44 research teams will partner with private biopharmaceutical companies to study and develop treatments for diseases ranging from Alzheimer’s to cancer.
Unfortunately, a new proposal from Congress could shake the foundation of this program. Ironically named the “Innovation Act,” the bill would stifle innovation and cripple Michigan’s economy by weakening the patents that enable medical research. To protect such research, Michigan representatives must reject this bill.